Biomimetic Therapeutics Inc

Biomimetic Therapeutics — Investor Presentation (March 2010)

19 slides from Biomimetic Therapeutics's investor presentation, Mar 12, 2010

  1. Slide 1: BMTI Sports Medicine Investor Analyst Meeting

    Slide 1: BMTI Sports Medicine Investor Analyst Meeting

    BMTI Sports Medicine NASDAQ: BMTI Investor Analyst Meeting March 11, 2010

  2. Slide 2: Early Wound Healing: Mechanism of Repair for Bone and Soft Tissue

    Slide 2: Early Wound Healing: Mechanism of Repair for Bone and Soft Tissue

    Hollinger+, 2008; Foster+, 2009 Injury Platelets TGF-ß PDGF FGF EGF VEGF IGF a-granules Wound Healing Chemotaxis Macrophages Phagocytes Progenitor Cells Mitogenesis Progenitor Cells Angiogenesis Vascular Smooth Muscle Cells Early Wound Healing Mechanism of Repair for Bone and Soft Tissue

  3. Slide 3: Role of PDGF-BB in Tendon Wound Healing

    Slide 3: Role of PDGF-BB in Tendon Wound Healing

    Repair Phase Effect of Exogenous PDGF-BB PDGF-BB is endogenously expressed in healing flexor tendons (Ahlen+,1994; Brogi+,1994; Letson and Dahners,1994; Duffy+,1995; Banes+,1995; Batten+, 1996; Harwood+,1999; Hildebrand+,1998; Yoshikawa+,2001; Affleck+,2002; Bouletreau+,2002; Tsubone+,2004; Weiler+,

  4. Slide 4: Normal and Diseased Human Primary Tenocytes Respond to rhPDGF-BB

    Slide 4: Normal and Diseased Human Primary Tenocytes Respond to rhPDGF-BB

    Normal and Diseased Human Primary Tenocytes Respond to rhPDGF-BB + 1 Courneya, J-P; 2 Atamas, S P; 1 Attorri, R; 1 Schon, L + 1 Union Memorial Hospital, Baltimore, MD, and 2 University of Maryland School of Medicine, Baltimore, MD

  5. Slide 5: Normal and Diseased Primary Human Tenocytes Respond to rhPDGF-BB

    Slide 5: Normal and Diseased Primary Human Tenocytes Respond to rhPDGF-BB

    + 1 Courneya, J-P; 2 Atamas, S P; 1 Attorri, R; 1 Schon, L + 1 Union Memorial Hospital, Johns Hopkins, Baltimore, and 2 University of Maryland School of Medicine, Baltimore Objective was to investigate the potential role of rhPDGF-BB on proliferation and chemotaxis of healthy and diseased tenocytes

  6. Slide 6: Evaluation of rhPDGF-BB in Combination with a Flowable Collagen Matrix for Acute Achilles Tendon Injury

    Slide 6: Evaluation of rhPDGF-BB in Combination with a Flowable Collagen Matrix for Acute Achilles Tendon Injury

    Evaluation of rhPDGF-BB in Combination with a Flowable Collagen Matrix for the Treatment of Acute Achilles Tendon Injury 1 Hee, C K; 1 Roden, C M; 1 Wisner-Lynch, L A; 1 Aguiar, D J; 2 Dines, J S; 3 Turner, A S; 3 Ruehlman, D L; 1 Kestler, H K; 1 Lynch, S E; 3 McGilvray, K C; 3 Lyons, A S; 3 Puttlit

  7. Slide 7: Achilles Tendon Repair: Clinical Need

    Slide 7: Achilles Tendon Repair: Clinical Need

    Surgical Intervention Conservative Treatment Rerupture rates are high for the current repair treatments (Leppilahti+, 1998; Maffulli, 1999) Rerupture Rate 1 – 9% 8 – 39% Achilles Tendon Repair Clinical Need Prolonged immobilization has negative effects on the rerupture rate Current methods require v

  8. Slide 8: Achilles Tendon Repair: Study Design

    Slide 8: Achilles Tendon Repair: Study Design

    Achilles Tendon Repair Study Design Hypothesis: rhPDGF-BB combined with a collagen matrix in an acute ovine Achilles tendon injury will improve the quality of the repaired tendon as assessed biomechanically and histologically after 8 weeks of healing. Model: Acute Achilles transection in skeletally

  9. Slide 9: Achilles Tendon Repair: Study Design

    Slide 9: Achilles Tendon Repair: Study Design

    A single Mason Allen stabilizing suture was placed After transection, the flowable collagen + buffer/PDGF was expressed between the transected tendon ends Achilles Tendon Repair Study Design

  10. Slide 10: Achilles Tendon Repair: Discussion

    Slide 10: Achilles Tendon Repair: Discussion

    Biomechanical Property 500 µg compared to matrix alone Dose-dependent increases were observed for the biomechanical properties Collagen+150 µg rhPDGF-BB was similar to matrix alone Collagen+500 µg rhPDGF-BB compared to matrix alone Ultimate Force 57% Stiffness 45% Energy to Failure 90% All groups sh

  11. Slide 11: Achilles Tendon Repair: Conclusion

    Slide 11: Achilles Tendon Repair: Conclusion

    The results of this pilot study suggest that rhPDGF-BB delivered in an injectable collagen matrix has promise for the treatment of tendon injuries Achilles Tendon Repair Conclusion

  12. Slide 12: Rotator Cuff Repair in an Ovine Model using rhPDGF-BB and Type I Bovine Collagen Matrix

    Slide 12: Rotator Cuff Repair in an Ovine Model using rhPDGF-BB and Type I Bovine Collagen Matrix

    Rotator Cuff Repair in an Ovine Model using a Combination Product Comprised of rhPDGF- BB and a Type I Bovine Collagen Matrix 1 Hee, C K; 1 Roden, C M; 1 Wisner-Lynch, L A; 1 Aguiar, D J; 2 Dines, J S; 2 Dines, D M; 3 Turner, A S; 3 Ruehlman, D L; 1 Kestler, H K; 1 Lynch, S E; 3 McGilvray, K C; 3 Ly

  13. Slide 13: Rotator Cuff Repair: Clinical Need

    Slide 13: Rotator Cuff Repair: Clinical Need

    The Rotator Cuff is slow to heal Repair tendon must sit still for a long period of time over as large an area of the healing zone as possible Healed rotator cuffs have better function High persistent tear rates reported: 10-90% (Boileau, JBJS 2005; Galatz, JBJS 2004; Frank, AJSM 2008) Rotator Cuff R

  14. Slide 14: Ovine Model of Rotator Cuff Repair: Study Design

    Slide 14: Ovine Model of Rotator Cuff Repair: Study Design

    Ovine Model of Rotator Cuff Repair Study Design Study Hypothesis: The application of rhPDGF-BB combined with a type I bovine collagen mesh will improve rotator cuff repair in an ovine model compared to fixation alone, as assessed biomechanically and histologically Study Design: Rotator Cuff Repair i

  15. Slide 15: RCR Histology

    Slide 15: RCR Histology

    Bone Bone Bone Bone Bone Bone Tendon Tendon Tendon Tendon Tendon Tendon A B C D E F RCR Histology Increased Sharpey’s Fibers with 75 and 150 µg rhPDGF-BB Normal Tendon Standard of Care 0 µg rhPDGF-BB 75 µg rhPDGF-BB 150 µg rhPDGF-BB 500 µg rhPDGF-BB

  16. Slide 16: Histology Outcomes

    Slide 16: Histology Outcomes

    Histology Outcomes Increased Tendon Repair Quality with 75 and 150 µg rhPDGF-BB Vascularity Inflammation Collagen Fiber Orientation Collagen Fiber Density Presence of Sharpey’s Fibers

  17. Slide 17: Biomechanics – Load at Failure

    Slide 17: Biomechanics – Load at Failure

    Load at Failure Groups (n=9) Bony Avulsion Repair Tissue Biomechanics – Load at Failure Significant Increase in rhPDGF-BB Treated vs. Fixation Alone Groups Newtons p-value Fixation Alone 910 ± 156 (N/A) Mesh Only 1120 ± 157 (0.42) Mesh + 75 µg rhPDGF-BB 1491 ± 224 (0.03) Mesh + 150 µg rhPDGF-BB 1487

  18. Slide 18: Ovine Rotator Cuff Repair

    Slide 18: Ovine Rotator Cuff Repair

    Ovine Rotator Cuff Repair rhPDGF-BB Positively Impacts Tendon-to-Bone Healing The results of this study indicate that rhPDGF-BB delivered in a collagen mesh positively impacts rotator cuff repair

  19. Slide 19: Data presented at 2010 ORS meeting support clinical trials in sports medicine

    Slide 19: Data presented at 2010 ORS meeting support clinical trials in sports medicine

    These data, presented at the 2010 Orthopedic Research Society (ORS) meeting provide strong support for the initiation of clinical trials utilizing rhPDGF-BB in sports medicine applications

Source: SEC EDGAR · 8-K filed Mar 12, 2010

More decks from Biomimetic Therapeutics Inc